BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26152337)

  • 1. Polymorphisms in the precursor microRNAs and aflatoxin B1-related hepatocellular carcinoma.
    Long XD; Huang XY; Yao JG; Liao P; Tang YJ; Ma Y; Xia Q
    Mol Carcinog; 2016 Jun; 55(6):1060-72. PubMed ID: 26152337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the coding region of X-ray repair complementing group 4 and aflatoxin B1-related hepatocellular carcinoma.
    Long XD; Yao JG; Zeng Z; Ma Y; Huang XY; Wei ZH; Liu M; Zhang JJ; Xue F; Zhai B; Xia Q
    Hepatology; 2013 Jul; 58(1):171-81. PubMed ID: 23390017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma.
    Long XD; Zhao D; Wang C; Huang XY; Yao JG; Ma Y; Wei ZH; Liu M; Zeng LX; Mo XQ; Zhang JJ; Xue F; Zhai B; Xia Q
    Epidemiology; 2013 Sep; 24(5):671-81. PubMed ID: 23788213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of a Disintegrin and Metalloproteinase with Thrombospondin Motifs 5 and Aflatoxin B1-Related Hepatocellular Carcinoma.
    Huang XY; Yao JG; Huang BC; Ma Y; Xia Q; Long XD
    Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):334-43. PubMed ID: 26677209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-24 modulates aflatoxin B1-related hepatocellular carcinoma prognosis and tumorigenesis.
    Liu YX; Long XD; Xi ZF; Ma Y; Huang XY; Yao JG; Wang C; Xing TY; Xia Q
    Biomed Res Int; 2014; 2014():482926. PubMed ID: 24800232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population.
    Long XD; Ma Y; Zhou YF; Ma AM; Fu GH
    Hepatology; 2010 Oct; 52(4):1301-9. PubMed ID: 20658464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-nucleotide polymorphisms in the coding region of a disintegrin and metalloproteinase with thrombospondin motifs 4 and hepatocellular carcinoma: A retrospective case-control study.
    Wang XZ; Tang WZ; Su QY; Yao JG; Huang XY; Long QQ; Wu XM; Xia Q; Long XD
    Cancer Med; 2019 Dec; 8(18):7869-7880. PubMed ID: 31663692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China.
    Long XD; Ma Y; Qu DY; Liu YG; Huang ZQ; Huang YZ; Lin ZH; Wei NB; Zhou SC
    Ann Epidemiol; 2008 Jul; 18(7):572-8. PubMed ID: 18504145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of DNA repair gene polymorphisms and aflatoxin B1 in the risk of hepatocellular carcinoma.
    Yao JG; Huang XY; Long XD
    Int J Clin Exp Pathol; 2014; 7(9):6231-44. PubMed ID: 25337275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
    Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
    Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
    Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
    J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RASSF1A hypermethylation is associated with aflatoxin B1 and polycyclic aromatic hydrocarbon exposure in hepatocellular carcinoma.
    Feng Y; Xue WJ; Li P; Sha ZY; Huang H; Rui L; Li HX; Mao QS
    Hepatogastroenterology; 2012 Sep; 59(118):1883-8. PubMed ID: 22172412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1.
    McGlynn KA; Rosvold EA; Lustbader ED; Hu Y; Clapper ML; Zhou T; Wild CP; Xia XL; Baffoe-Bonnie A; Ofori-Adjei D
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2384-7. PubMed ID: 7892276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
    Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI
    Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States?
    Hoque A; Patt YZ; Yoffe B; Groopman JD; Greenblatt MS; Zhang YJ; Santella RM
    Nutr Cancer; 1999; 35(1):27-33. PubMed ID: 10624703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [p53 gene mutation in hepatocellular carcinoma].
    Jiang W; Lu Q; Pan G
    Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk.
    Long XD; Ma Y; Zhou YF; Yao JG; Ban FZ; Huang YZ; Huang BC
    BMC Cancer; 2009 Nov; 9():400. PubMed ID: 19919686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients.
    Yu G; Xiao Q; Ma XP; Chen X; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Sun J; Conran C; Zheng SL; Xu J; Yu L; Jiang DK
    Tumour Biol; 2016 Jul; 37(7):8961-72. PubMed ID: 26753964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.